_1421936-85-7.png "24084 | Iclepertin (BI-425809)")
_2408839-73-4.png "20636 | Edecesertib ( GS-5718 )")
_412003-95-3.png "2091204 | 2,4-二甲基-5-羟基嘧啶")
ethan-1-one_1060810-24-3.png "171454 | 1-(4-溴-6-甲基吡啶-2-基)乙-1-酮")
_1616632-77-9.png "51802 | TIC10 ( ONC201 )")
重点产品更多 >>
| 编号 | 化学名称 | Cas号 | 纯度 |
|---|---|---|---|
| 25076 | HC-7366 HC-7366 is a potent and selective activator of the general control nonderepressible 2 |
2803470-63-3 | ≧98.0% |
| 41788 | CB-6644 CB-6644 acts as a noncompetitive ATPase inhibitor. Additionally, it can inhibit RUVBL |
2316817-88-4 | 96.33% |
| 25148 | Atebimetinib 阿替美替尼（IMM-1-104）是一种口服的小分子MEK1和MEK2激酶变构抑制 |
2669009-92-9 | ≧98.0% |
| 25075 | LLL12 LLL12是一种强效的STAT3抑制剂。LLL12在小鼠异种移植物模型中显示出 |
1260247-42-4 | ≧97.0% |
| 181121 | AZD-5904 AZD5904是一个有效的口服生物利用率MPO抑制剂。在临床前研究中,AZ |
618913-30-7 | ≧98.0% |
| 237071 | Flavopiridol ( 夫拉平度 ) Alvocidib is a synthetic dihydroxyflavone that is 5,7-dihydroxyflavone which is subst |
146426-40-6 | ≧98.0% |
| 24107 | LXH-3-71 LXH-3-71是一种新型“分子胶”，可诱导PHGDH和DDB1-CUL4泛素连接酶之 |
2251753-65-6 | ≧97.0% |
| 20509 | GLPG3667 GLPG3667 是一种口服强效选择性小分子 TYK2 抑制剂，正在开发用于治 |
2308520-97-8 | ≧98.0% |
| 121431 | KW-2478 KW-2478 是一种针对人类热休克蛋白 90 (Hsp90) 的药物，具有潜在的抗 |
819812-04-9 | 98% |
| 18576 | VU0467154 VU0467154 is a positive allosteric modulator of theM4 muscarinic acetylcholine recept |
1451993-15-9 | ≧98.0% |
| 171452 | BGB 15025 ; BGB-15025 ; BGB15025 BGB-15025 是一种有效的选择性 HPK1 抑制剂，在多种肿瘤模型中作为 |
2766481-17-6 | ≧98.0% |
| 17021601 | LY3039478 ( Crenigacestat ) LY3039478 ( Crenigacestat ) 是一种选择性 NOTCH1 抑制剂，通过阻断 VEGFA/ |
1421438-81-4 | ≧98.0% |
| 711401 | Eganelisib ( IPI-549 ) Eganelisib (IPI-549) 是一种首创、口服、高选择性 PI3Kγ 抑制剂，单独 |
1693758-51-8 | ≧98.0% |
| 24067 | PBT434 氢溴酸盐 PBT434, also known as ATH434 , is a novel, brain-penetrant, inhibitor of α-synuclein |
1232841-78-9 | ≧98.0% |
| 233141 | NXP-800 ( CCT361814 ) NXP800 是一种口服小分子热休克因子 1 (HSF1) 通路抑制剂。 NXP800 可 |
1693734-80-3 | ≧98.0% |